Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,454 | -55,672 | -32,422 | -19,999 | -8,851 |
| Depreciation Amortization | 1,230 | 494 | 256 | 88 | 44 |
| Accounts receivable | 5,000 | 12,500 | 1,000 | -1,000 | N/A |
| Accounts payable and accrued liabilities | 4,366 | 3,904 | -886 | 1,891 | 972 |
| Other Working Capital | 12,476 | 17,009 | -2,230 | 3,086 | 3,031 |
| Other Operating Activity | 2,661 | -8,302 | 6,485 | 2,363 | 179 |
| Operating Cash Flow | $-45,721 | $-30,067 | $-27,797 | $-13,571 | $-4,625 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,743 | -2,300 | -707 | -353 | -114 |
| Investing Cash Flow | $-2,743 | $-2,300 | $-707 | $-353 | $-114 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 964 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 492 | 415 | 349 | 208 |
| Debt Repayment | 0 | -434 | -358 | -242 | -190 |
| Common Stock Issued | 40,677 | 12,053 | 78,892 | 16,699 | 11,329 |
| Other Financing Activity | -3,177 | -690 | -2,941 | -64 | -509 |
| Financing Cash Flow | $38,464 | $11,420 | $76,008 | $16,742 | $10,837 |
| Beginning Cash Position | 41,749 | 62,697 | 15,192 | 12,375 | 6,276 |
| End Cash Position | 31,749 | 41,749 | 62,697 | 15,192 | 12,375 |
| Net Cash Flow | $-10,000 | $-20,948 | $47,504 | $2,818 | $6,099 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,721 | -30,067 | -27,797 | -13,571 | -4,625 |
| Capital Expenditure | -2,743 | -2,300 | -707 | -353 | -114 |
| Free Cash Flow | -48,463 | -32,368 | -28,504 | -13,924 | -4,739 |